GE HealthCare Technologies annual stock-based compensation
2021
2022
2023
2024
2025
GE HealthCare Technologies Stock-Based Compensation Growth & History (GEHC)
GE HealthCare Technologies's stock-based compensation was $130.0M for fiscal 2025.
View full GE HealthCare Technologies company overviewGE HealthCare Technologies annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $130.0M | $5.0M | +4.00% |
| 2024 | 2024-12-31 | $125.0M | $11.0M | +9.65% |
| 2023 | 2023-12-31 | $114.0M | $47.0M | +70.15% |
| 2022 | 2022-12-31 | $67.0M | −$9.0M | −11.84% |
| 2021 | 2021-12-31 | $76.0M | — | — |
GE HealthCare Technologies quarterly stock-based compensation
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $45.0M | $11.0M | +32.35% |
| Q1 2026 | 2026-03-31 | $35.0M | $13.0M | +59.09% |
| Q4 2025 | 2025-12-31 | $36.0M | $3.0M | +9.09% |
| Q3 2025 | 2025-09-30 | $38.0M | $16.0M | +72.73% |
| Q2 2025 | 2025-06-30 | $34.0M | −$2.0M | −5.56% |
| Q1 2025 | 2025-03-31 | $22.0M | −$12.0M | −35.29% |
| Q4 2024 | 2024-12-31 | $33.0M | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $22.0M | −$7.0M | −24.14% |
| Q2 2024 | 2024-06-30 | $36.0M | $8.0M | +28.57% |
| Q1 2024 | 2024-03-31 | $34.0M | $10.0M | +41.67% |
| Q4 2023 | 2023-12-31 | $33.0M | $24.0M | +266.67% |
| Q3 2023 | 2023-09-30 | $29.0M | $10.0M | +52.63% |
| Q2 2023 | 2023-06-30 | $28.0M | $8.0M | +40.00% |
| Q1 2023 | 2023-03-31 | $24.0M | $5.0M | +26.32% |
| Q4 2022 | 2022-12-31 | $9.0M | — | — |
| Q3 2022 | 2022-09-30 | $19.0M | — | — |
| Q2 2022 | 2022-06-30 | $20.0M | — | — |
| Q1 2022 | 2022-03-31 | $19.0M | — | — |
GE HealthCare Technologies stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-12-31, GE HealthCare Technologies's stock-based compensation increased from $76.0M to $130.0M, a change of $54.0M. The latest reported quarter, Q2 2026, shows $45.0M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GE HealthCare Technologies source filings ↗